Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
Hepatocellular carcinoma (HCC) ranks as a leading cause of common cancer and cancer-related death. The major etiology of HCC is due to chronic hepatitis virus including HBV and HCV infections. Scheduled HCC surveillance in high risk populations improves the early detection rate and the feasibility o...
Main Authors: | Wei Teng, Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Su |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1729 |
Similar Items
-
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
by: Piero Colombatto, et al.
Published: (2022-03-01) -
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
by: Chih-Lang Lin, et al.
Published: (2023-06-01) -
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
by: Meng-Ju Lin, et al.
Published: (2023-07-01) -
The Yin and the Yang of Treatment for Chronic Hepatitis B—When to Start, When to Stop Nucleos(t)ide Analogue Therapy
by: Samuel Hall, et al.
Published: (2020-08-01) -
Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon
by: Peipei Wang, et al.
Published: (2023-01-01)